The new devices – NovoPen 6 and NovoPen Echo Plus – are insulin self-injection pens ... companies have developed smart insulin pens, notably Medtronic with its InPen device, but Novo Nordisk ...

Insulcloud today announced its strategic expansion into the U.S. following FDA clearance for its Insulclock CAP smart device.

This new insulin might mean fewer injections and better blood sugar control — both up and down — for diabetes patients.

Insulclock CAP, which received EU approval in 2018, assists users in detecting and avoiding errors in insulin administration.

has developed a type of "smart" insulin that when tested in mouse and minipig models successfully regulated blood glucose levels for up to one week after just one injection. In their paper ...

NovoPen ®, the first insulin pen injector, was introduced in 1985. This article reviews the published evidence over two decades of use of the NovoPen ® family of injection devices in diabetes ...

Scientists have engineered a modified insulin that reduces its activity at low glucose levels. This glucose-responsive insulin could prevent people with diabetes from experiencing dangerously low ...

A new type of insulin that can adapt to blood sugar levels has been successfully tested in lab studies and animal trials.

For years, the treatment of type 1 diabetes was dependent on an insulin regimen -- injections ... thanks to the development of a smart version of insulin that will reportedly adjust itself ...

There are numerous device-related strategies for reducing pain and embarrassment, including insulin pens, finer gauge needles, injection ports, needleless injectors, and other injection assistance ...

Yes, people living with T2D can manage their condition effectively without using insulin injections. Instead of insulin, they may use a combination of other medications and lifestyle changes.

If these sheets work effectively, the technology could spare diabetes patients from the troublesome task of taking daily insulin injections ... and Medical Devices Agency (PMDA) on Sept.